Home

Letmo Research

We provide scientific due diligence and in-depth investment research, with particular strength in biotechnology, biomedicine, gene therapy and genomics. What we do best is judging whether a technology or a business model can actually work, and finding the plans that cannot, including the ones built to mislead. We write research to order and publish reports on this site: some are public, the rest are open to members. When the opportunity is right, we also invest our own capital. We choose to make as much of our work public as we can, so it can be reviewed, challenged and improved over time (all 1,319 trades and 424 deposits and withdrawals since 2017 are public).

As of 2026-11-19 16:00 ET

View full performance
  • Portfolio
  • SPY

Drag across the chart to focus on a period; click to pin a month

Cumulative Return
505.72%SPY: 230.07%
Annualized Return
21.76%SPY: 13.94%
Months Ahead of SPY
60.36%67 of 111 months
Date
2017-09-25 to 2026-11-19
0%200%400%201820192020202120222023202420252026Sold all index ETFs; 100% hand-picked stocks since-10%0%10%